Proteinase-activated receptor-2 (PAR 2 ) belongs to a new G protein-coupled receptor subfamily activated by serine proteinases. PAR 2 has been demonstrated to play a role during inflammation and immune response in different tissues including the skin. We examined whether PAR 2 is functionally expressed by cutaneous human primary skin mast cells (HPMC) and the human mast cell line 1 (HMC-1). Reverse transcription-polymerase chain reaction and FACS analysis show expression of PAR 2 both at the RNA and protein level. HPMCs and HMC-1 also express PAR 1 , PAR 3 , and PAR 4 . Ca-mobilization studies demonstrate functional PAR 2 expressed by human skin mast cells, as shown by natural and synthetic PAR 2 agonists. PAR 2 agonists induced histamine release from HPMC indicating a role of PAR 2 in regulating inflammatory and immune responses by skin mast cells. Doubleimmunofluorescence staining reveals colocalization of PAR 2 with tryptase in the majority of human skin mast cells. In conclusion, trypsin and tryptase as well as specific agonists for PAR 2 were able to induce Ca 2 þ mobilization in HPMCs, and agonists of PAR 2 induce the release of histamine from these cells. Thus, PAR 2 may be an important regulator of skin mast cell function during cutaneous inflammation and hypersensitivity.
INTRODUCTION
Proteinase-activated receptor-2 (PAR 2 ) belongs to a new subfamily of G-protein-coupled receptors with seven transmembrane domains. At present, four PARs have been identified by molecular cloning (Coughlin, 2000; Macfarlane et al., 2001; Ossovskaya and Bunnett, 2004) . PAR 2 is expressed in various tissues and is also found in numerous cells involved in inflammatory and immune responses (reviewed in Steinhoff et al., 2005) . On the other hand, some cells, for example, human platelets, do not express PAR 2 (Blackhart et al., 1996; Hwa et al., 1996; Steinhoff et al., 2005) .
A variety of serine proteases (eg trypsin and tryptase) as well as microbiological agents (bacteria, house-dust mite allergens) are capable of activating PAR 2 (reviewed in Steinhoff et al., 2005) .
In the skin, PAR 2 is expressed by keratinocytes, activated endothelial cells, and sensory nerves (Hou et al., 1998; Steinhoff et al., 1999; Shpacovitch et al., 2002) . PAR 2 upregulates cytokine release and cell adhesion molecule expression during experimentally induced contact dermatitis via nitric oxide (Seeliger et al., 2003) . It has also been shown that PAR 2 can regulate cutaneous inflammation via a neurogenic mechanism (Steinhoff et al., 2000) . Together, these results indicate that PAR 2 is an important regulator of immune and inflammatory responses in the skin (Steinhoff et al., 2005) .
Human mast cells produce a broad array of proinflammatory mediators including preformed mediators such as histamine, proteoglycans, and neutral proteinases like tryptase and chymase. Many of these mediators are stored in intracellular secretory granules and released by triggered exocytosis after mast cell activation. Mast cells have been implicated in many skin diseases including inflammation, hypersensitivity, and tissue repair (Benoist and Mathis, 2002) . Via histamine release, mast cells communicate with sensory nerves and blood vessels, thereby regulating neurogenic inflammation and pruritus (Steinhoff et al., 2003) .
Various in vitro and in vivo investigations of different species suggest a functional role of PAR 2 on mast cells in certain tissues. So far, PAR 2 expression has been demonstrated on human mast cell line 1 (HMC-1) and in mast cells from various normal tissues (He et al., 2005; Steinhoff et al., 2005) . In other tissues, however, evidence for the expression and/or function of PAR 2 in mast cells was lacking such as airways (He et al., 2004a, b) .
Histamine is rapidly released upon mast cells stimulation and is a powerful mediator on blood vessels causing smooth muscle contraction, vasodilatation, and plasma extravasation from capillaries. Histamine mediates itch responses especially at the beginning of an inflammatory response by activating histamine receptors (HR) on cutaneous sensory nerves (Xie and He, 2005) .
Mast cell tryptase is one of the crucial molecules released by mast cells during inflammation, allergic reactions, and tissue repair (Fiorucci and Ascoli, 2004) . It is able to cleave many extracellular substrates involved in inflammation and tissue repair (Tam and Caughey, 1990; Lohi et al., 1992; Walls et al., 1992) . Tryptase activates PAR 2 on several cells indicating that at least a part of the tryptase-mediated effects in the skin may be induced via PAR 2 activation (Corvera et al., 1997; Steinhoff et al., 1999 Steinhoff et al., , 2000 Shpacovitch et al., 2002) .
The hypothesis that tryptase may effect mast cell function is intriguing because it would mean that proteases may be potential modulators of skin mast cell function via PAR 2 . This may have implications for our understanding of cutaneous mast cells function under physiological and pathophysiological conditions and therapeutic interventions.
As tryptase is an important regulator of cutaneous inflammation and immunity, we analyzed whether skinderived human mast cells may express functional PAR 2 and whether mast cell tryptase is capable of stimulating mediator release from these cells via PAR 2 . Therefore, the aim of this study was to (1) detect the expression of PAR 2 on human primary skin mast cells (HPMC) in human skin, both at the RNA-and protein level, (2) investigate whether PAR 2 is functional on cutaneous mast cells using specific PAR 2 agonists, trypsin and tryptase, (3) determine whether PAR 2 agonists induce histamine release from skin HPMCs.
RESULTS
Detection of PAR 1-4 mRNA by reverse transcription-polymerase chain reaction analysis
To detect expression of PAR 1-4 mRNA in freshly isolated skinderived HPMCs and the mast cell line HMC-I, RNA was extracted, reverse transcribed, and amplified with specific primers for PAR 1 to PAR 4 (Figure 1 ). In both cell types (panel a: HMC-1 and panel b: HPMCs, lanes 1-4), reverse transcription-polymerase chain reaction (RT-PCR) of mRNA revealed specific products in the expected range (PAR 1 : 708 bp, PAR 2 : 436 bp, PAR 3 : 382 bp, and PAR 4 : 392 bp). PAR 2 was identical to the bands received from keratinocytes and endothelial cells (Steinhoff et al., 1999; Shpacovitch et al., 2002) . Each sample was analyzed at least twice. The presented experiment is representative of four independent experiments, with similar results. The PAR 2 PCR products of the cell line HMC-1 were sequenced and found to correspond to published sequences (data not shown).
Flow cytometric analysis of PAR 2 in human dermal mast cells and HMC-1 cells PAR 2 was also detected in both types of cells at the protein level by flow cytometry (Figure 2 ). Each figure represents an analysis of 10,000 events. The well-established PAR 2 -B5 antibody was used for staining of PAR 2 , both at the cell surface and intracellularly. PAR 2 staining was correlated with the secondary antibody (FITC-conjugated anti-rabbit IgG) signal as a negative control. As shown in panel a, HPMCs show about 47% cell surface staining for PAR 2 and approximately 99% intracellular staining for PAR 2 . In contrast, secondary antibody staining demonstrated only 0.59 and 0.27% positive cells demonstrating specificity of this staining. Similar results were observed in HMC-1 cells (Figure 2b ). Although cell surface staining for PAR 2 was about 57% in HMC-1 cells, intracellular levels for PAR 2 were approximately 99% in these cells. Again, secondary antibody staining was in the background range (Figure 2b ). (Wakita et al., 1997 , Shpacovitch et al., 2002 . Furthermore, PAR 2 agonists induce the upregulation of NF-kB in keratinocytes and dermal endothelial cells (Shpacovitch et al., 2002; Buddenkotte et al., 2005) , a crucial transcription factor during inflammation and the immune response. Similarly, tryptase regulates cytokines, cell adhesion molecules, and extracellular matrix proteins in the skin and thus appears to play a pivotal role during cutaneous inflammation, allergic responses, extracellular matrix regulation, and tumor growth (Payne and Kam, 2004) . Therefore, we determined whether the endogenous activator of PAR 2 , tryptase, colocalizes with PAR 2 in human skin mast cells. PAR 2 immunoreactivity was localized in dermal mast cells within human skin (Figure 3a) . Interestingly, some (arrowheads) but not all mast cells stained for PAR 2 , which confirms our FACS data for cell surface staining. Intense immunoreactivity for PAR 2 (green) was observed in several dermal mast cells, which also displayed immunoreactivity for tryptase (red), as shown by double immunofluorescence (arrowheads). Thus, PAR 2 colocalizes with mast cell tryptase in several human dermal mast cells in close proximity to dermal blood vessels (arrows). Control staining for PAR 2 preabsorption experiments (Steinhoff et al., 1999) did not exhibit immunoreactivity in skin cells verifying specificity for PAR 2 in human skin mast cells (Figure 3b ).
Effects of PAR 2 agonists on [Ca 2 þ ] I in human primary skin mast cells
We have shown that both HPMCs and HMC-1 cells express PAR 2 mRNA and protein at similar levels. To determine the role of PAR 2 in primary human skin mast cells, we performed functional studies in PAR 2 activation merely in HPMCs. We measured agonist-induced Ca 2 þ mobilization in HPMCs to confirm expression of functional PAR 2 . Trypsin (0.1 mM) caused a rapid increase in intracellular Ca 2 þ (Figure 4) , with a maximum at 3-4 seconds. PAR 2 activation with activating peptide (AP) for PAR 2 (10 mM) and trypsin (0.1 mM), as shown in Figure Histamine release was measured in dermal mast cells from three separate preparations. Stimulation of HPMCs with antiIgE led to a 23% increase in the release of total histamine. This effect could be further enhanced (up to 34%) when HPMCs were pretreated with PAR 2 -AP (10 À4 M). When HPMCs were stimulated with the activating PAR 2 -AP (10 À4 M) alone, a 9.5% increase in the release of total histamine was observed. Non-activating PAR 2 -RP (10 À4 M) had no effect on histamine release. HPMCs responded to PAR 2 -AP within 15 minutes. This time course is comparable to that of activation by anti-IgE. Using highly purified (up to 70%) instead of only moderately purified mast cells, a comparable level of histamine release was observed (Figure 7) . DISCUSSION A considerable number of reports suggest a crucial role of PAR 2 in cutaneous inflammation and hypersensitivity, mainly by releasing neuropeptides and cytokines from nerves and immunocompetent cells. The aim of this study was to determine the functional expression of PAR 2 in primary human skin mast cells. Our results indicate that PAR 2 is expressed by HPMCs of normal human skin as well as by HMC-1 cells. This was confirmed at the protein level using FACS analysis and immunofluorescence. Ca-mobilization studies reveal PAR 2 to be functional in HPMCs using various PAR 2 -agonists. Finally, PAR 2 agonists stimulate histamine release from HPMCs. Together, the activation of skin mast cells may modulate inflammatory and immune responses in human skin, thereby contributing to skin diseases in which mast cells are involved. We used two methods to detect PAR 2 in HPMCs of human skin. We localized immunoreactive PAR 2 in approximately 50% of skin dermal mast cells using antibodies to distinct epitopes. The same results were obtained with each antibody. Preabsorption with the peptide antigen abolished the signal, which confirms specificity. These results demonstrate that PAR 2 protein is localized in human skin mast cells, notably around blood vessels. Second, we detected PAR 2 protein in cultured HPMCs by FACS analysis, which confirms results received by RT-PCR and immunofluorescence in human skin.
As receptor expression and immunostaining does not necessarily include biological function, we obtained evidence for the expression of functional PAR 2 on skin mast cells by examining the effects of trypsin, tryptase, and AP for PAR 2 on [Ca2 þ ] I . Our results show that trypsin and tryptase as well as specific AP for PAR 2 were able to induce Ca 2 þ mobilization in HPMCs, indicating that functional PAR 2 is expressed by primary skin mast cells. In support of our results from human tissue, He et al. (2002) recently described PAR 2 -induced Ca 2 þ -mobilization on cultured primary human colon mast cells. However, He et al. (2002) were unable to find functional PAR 2 on human airway tissue mast cells, suggesting specificity for PAR 2 function in various human tissues (He et al., 2004a, b) . Histamine is an important mediator during cutaneous inflammation and hypersensitivity. Our data indicate that PAR 2 is capable of stimulating the release of histamine from human breast mast cells. This is in agreement with other papers that demonstrated that PAR 2 agonists induce histamine release from human colon mast cells and human foreskin mast cells (He et al., 2004a (He et al., , b, 2005 afferent neurons (Steinhoff et al., 2000) , but also directly by stimulating histamine release from skin mast cells. Accordingly, PAR 2 may mediate pruritic effects in the skin not only by acting directly on sensory ''itch'' fibers (Steinhoff et al., 2003) but also via histamine binding to HRs on sensory nerves (Figure 8 ). The biological relevance of PAR 2 in human skin physiology and pathophysiological conditions is, however, not clear as of yet and has to await further clarification. Histamine represents an important molecule in the ''neuro-immuno'' communication network between sensory nerves and mast cells (Steinhoff et al., 2003) . Histamine, as a proinflammatory, mediator is rapidly released from mast cells upon degranulation. In human skin, histamine mediates vasodilatation, plasma extravasation, and pruritus by activating HRs. To date, four HRs H 1-4 R are described which belong to the G-protein-coupled receptor family, with seven transmembrane domains. In the skin, H 1 R is localized in fibroblasts (Johnson and Johnson, 1990 ) and endothelial cells (Baenziger et al., 1981) , and both H 1 R and H 2 R are expressed on keratinocytes (Koizumi and Ohkawara, 1999; Kanda and Watanabe, 2002 ). Mast cells express functional H 2 R and H 4 R, which upon binding of histamine activate autocrine feedback mechanisms and thereby act as immunomodulatory (Lippert et al., 2004) . Recently, it was also demonstrated that histamine regulates T-cell activation and maturation into TH1/TH2 subtypes (Jutel et al., 2001) .
In contrast, PAR 2 agonist peptides did not stimulate the release of tryptase from HPMCs in our experiments (data not shown). Normally, tryptase is simultaneously released with histamine from identical mast cell granules. Thus, one explanation may be that the concentration of tryptase was under detectable amounts with two different antibody kits used in our experiments. Alternatively, the stimulated release of histamine and tryptase may vary among tissues, as shown for foreskin mast cells and human tonsil mast cells (He et al., 2005) . In colon mast cells, for example, PAR 2 agonists were also capable of stimulating tryptase as well as histamine in vitro. Therefore, the question whether PAR 2 is able to regulate mast cell function in an autocrine manner via PAR 2 still remains to be further explored.
Together, from our data we propose that PAR 2 contributes to inflammation and hypersensitivity in human skin by activating intracellular Ca-stores and regulating histamine release in human skin tissues. The precise mechanism of neuronal and vascular inflammatory interactions between PAR receptors and HRs on neurons and endothelial cell is still unknown, and has to await further clarification (Figure 8 ).
MATERIALS AND METHODS

Reagents
All chemicals and reagents were obtained from appropriate commercial sources.
Purified trypsin was purchased from Sigma (Deisenhofen, Germany). Human b-tryptase was expressed in Pichia pastoris (Niles et al., 1998) . Synthetic agonist peptide for PAR 2 , as well as control PAR 2 peptide, corresponding to the tethered ligand of human PARs, were purchased from Ortho-McNeil Pharmaceutical, Spring House, PA. The sequences of the AP and control (reverse) peptide (RP) for PAR 2 were: SLIGRL-NH 2 (AP) and LRGILS-NH 2 (RP). The rabbit monoclonal antibody (B5) to PAR 2 was a kind gift from Dr M. Hollenberg, Calgary, Canada. The following secondary antibody was used: affinity-purified goat anti-rabbit IgG coupled to FITC was from Dianova (Hamburg, Germany). Fluo-4-AM was from Molecular Probes, Eugene, OR. Other materials include: tissue culture reagents (PAA Laboratories GmbH, Cö lbe, Germany; Sigma); molecular biology reagents (Promega, Mannheim, Germany; Eppendorf Hamburg, Germany; Sigma), and oligonucleotide primers (Invitrogen, Paisley, Scotland).
Cell culture
The human leukemic mast cell line HMC-1, kindly provided by Dr J. H. Butterfield (Rochester, MN) was cultured in Iscoves' medium, supplemented with 10% fetal calf serum, 10 mM monothioglycerol and antibiotics (streptomycin and penicillin), at 371C in a humidified atmosphere containing 5% CO 2 . The cell line was passaged every 3-4 days. activation on endothelial cells (Bull et al., 1991) and sensory nerves (Barnes, 1991) . (4) Tryptase stimulates neuropeptides release (substance P (SP), calcitoningene related peptide (CGRP)) from sensory nerves via PAR 2 (Steinhoff et al., 2000) . (5) Tryptase activates endothelial cells expressing PAR 2 (Molino et al., 1997) .
(6) Stimulation of PAR 2 on the cell membrane of mast cells via tryptase. (7) Neuronal substance P induces histamine and tryptase release from skin mast cells (Ebertz et al., 1987; Steinhoff et al., 2000) . (8) Calcitonin-gene related peptide induces vasodilation and hyperemia via interacting with the type 1 calcitoningene related peptide receptor on arterioles (Brain et al., 1985; Holzer, 1998) . (9) Mast cells were isolated from human skin tissue and purified by positive sorting using the monoclonal antibody YB5.B8 against the Kit receptor (CD 117) and a secondary magnetic microbead-coupled antibody, as previously described (Grü tzkau et al., 2000) . Viability of mast cells was over 95%, as determined by trypan blue staining. Skin specimens were obtained during surgical breast reductions, with informed consent.
All use of human skin was conducted according to the Declaration of Helsinki Principles and was approved by Institutional Review Boards of both University of Mü nster and the Charite University of Berlin.
RNA isolation and semiquantitative RT-PCR
RNA isolation and RT-PCR analysis were performed as previously described (Shpacovitch et al., 2002) . For PCR amplifications, the following primer pairs were used: PAR 1 : forward primer 5 The PCR products for PAR 1-4 were amplified from the same undiluted complementary DNA. The amplification program was as follows: PAR 1 was amplified by the following program: 1 cycle 941C, 5 minutes; followed by 35 cycles of 941C, 1 minute; 531C, 1 minute; 721C, 1 minute; and a final cycle of 721C, 7 minutes. PAR 2 was amplified using the following program: 1 cycle 941C, 5 minutes; followed by 35 cycles of 941C, 1 minute; 581C, 1 minute; 721C, 1 minute; and a final cycle of 721C, 7 minutes. PAR 3 was amplified using the following program: 1 cycle 941C, 5 minutes; followed by 35 cycles of 941C, 1 minute; 671C, 1 minute; 721C, 1 minute; and a final cycle of 721C, 7 minutes. PAR 4 was amplified using the following program: 1 cycle 941C, 5 minutes; followed by 35 cycles of 941C, 1 minute; 631C, 1 minute; 721C, 1 minute; and a final cycle of 721C, 7 minutes. Samples were resolved on a 2% (w/v) agarose gel and stained by ethidium bromide. The products were run against a 100 bp DNA ladder (Enzymes, Muenster, Germany) and were imaged under UV light. PCR products for PAR 2 of the cell line HMC-1 were purified using a Qiaquick gel extraction kit (Qiagen, Melbourne, Australia) and DNA sequences were determined by SeqLab GmbH (Gö ttingen, Germany).
Flow cytometry
To detect cell surface PAR 2 , 5 Â 10 5 cells were incubated in 100 ml phosphate-buffered saline (PBS)/1% fetal calf serum with rabbit monoclonal antibody B5 against PAR 2 (dilution 1:100 for HMC-1 and 1:25 for primary skin mast cells) for 15 minutes at room temperature. Goat anti-rabbit IgG antibody served as control. After washing in PBS/1% fetal calf serum primary antibody was detected with a FITC-conjugated goat anti-rabbit IgG (HMC-1: 1:100, primary skin mast cells: 1:50) for 15 minutes at room temperature. Then cells were washed, resuspended in 500 ml PBS containing 2 mM EDTA and kept in the dark at room temperature. Cells were analyzed using a FACScalibur (Becton Dickinson, Heidelberg, Germany), equipped with CellQuestPro software.
To detect intracellular PAR, cells were fixed with 2% paraformaldehyde and permeabilized with 0.2% saponin. Cells were incubated in 100 ml 2XPER with rabbit monoclonal antibody B5 against PAR 2 (dilution: see above) for 15 minutes at room temperature. Goat anti-rabbit IgG antibody served as control. After washing in 2XPER, primary antibody was detected with FITC-conjugated goat anti-rabbit IgG (dilution: see above) for 15 minutes at room temperature. Then cells were washed, resuspended in 500 ml PBS containing 2 mM EDTA and kept in the dark at room temperature until cytofluorometric analysis.
Double immunofluorescence
Double-immunofluorescence staining was performed with modifications, as recently described (Steinhoff et al., 1999) . Briefly, skin biopsies were taken from healthy volunteers (n ¼ 3) or post-operative material (n ¼ 5) (controls) or lesional and non-lesional skin of patients suffering from atopic dermatitis (n ¼ 6) or urticaria (n ¼ 7). Patients did not receive topical anti-inflammatory agents at sites of inflammation, systemic medications or UV-irradiation within 2 weeks before obtaining biopsies. The patients gave informed consent to the biopsies. Tissues were fixed in Bouin's fixative for 12 hours, washed, embedded in OCT compound (Miles, Elhhant, IN) , and stored at À801C. Before use, specimens were sectioned, postfixed with Bouin's fixative for 20 minutes and washed in PBS, pH 7.4 for 45 minutes. Sections were incubated with antibodies against PAR 2 (PAR 2 -B5 1:500, PAR 2 -2C 1:50, and PAR 2 -N-19 1:200) overnight at 41C. Next day, slides were washed and incubated with mouse monoclonal antibody against mast cell tryptase (1:2,000) for 1 hour at room temperature. After thorough washing in PBS for 3 Â 10 minutes, slides were incubated in a PBS buffer containing 5% normal goat serum, 1% BSA with a cocktail of secondary antibodies (goat-anti-rabbit IgG 1:200, sheep-anti-goat IgG 1:200, or donkey-anti-mouse IgG 1:100). After washing in a dark chamber, slides were mounted in Vectashield (Vector, Burlingame, CA) and examined using a Leica microscope (Leica DMR, Heidelberg, Germany). In controls, primary polyclonal antibodies were preincubated 24-48 hours with corresponding peptides (10-100 mM) used for immunization or matched monoclonal Ig control antibodies were used to elucidate background staining.
Determination of cytoplasmic calcium concentration [Ca2 þ ] I with confocal laser scanning microscopy
Freshly isolated human dermal mast cells that normally grow in suspension, were cultivated overnight in laminin-coated Petri wells. Subsequently, more than 70% of these mast cells were adherent to the laminin-coated surface. The adherence of these cells was an essential prerequisite for the determination of Ca influx. The increase of the intracellular Ca 2 þ concentration in mast cells was visualized using a confocal laser scanning microscope (Leica, Heidelberg, Germany) with a water immersion objective XLUMPlanFI 20 Â 0.95w (Olympus). Cells were loaded with 5 mM of Ca 2 þ -sensitive, membrane-permeable fluorescent dye Fluo-4-AM (Molecular Probes, Eugene, OR) for 30 minutes at room temperature. After Fura-4-AM loading, cells were washed 3 times with DMEM without fetal calf serum and supplemented in 2 ml DMEM. Activating and reverse peptides for PAR 2 (final concentration 10 mM) was added to the cells. The final concentration for the PAR 2 agonists trypsin or tryptase were 0.1 and 10 mM, respectively. Fluo-4-AM was excited by the 488 nm line of the krypton-argon laser. Fluorescence from green www.jidonline.org 753 channels was collected by photomultiplier tube using filters for 510-560 nm. Images were processed off-line using NIH Image J software. In each experiment, Ca 2 þ influx was measured over a period of 10 minutes.
Histamine release assay
Dermal mast cell suspensions were divided into aliquots, washed twice with PAG-CM (PIPES albumin glucose buffer containing 3 mM CaCl 2 and 1.5 mM MgCl 2 ), and resuspended at 1 Â 10 4 cells/ml. Cells were incubated for 30 minutes at 371C with agonist peptides as well as control PAR 2 peptides (final concentration 10 À4 M) before they were challenged with anti-IgE (dilution 1:20,000). Another portion of cells was kept in buffer only (PAG-CM) to measure spontaneous release. Supernatants were stored at À201C until measurement. Total cellular histamine contents were assessed upon cell lysis with 1% perchloric acid. Histamine amounts were determined by an automated fluorescence method (Siraganian, 1975) , using an autoanalyzer (Borgwald Technik, Hamburg, Germany).
